US 11,696,881 B2
Oral care compositions comprising hops beta acids and fluoride ions
Arif Ali Baig, Mason, OH (US); Tammy Baker, Cincinnati, OH (US); Aaron Reed Biesbrock, Maineville, OH (US); and Samuel James St. John, Cincinnati, OH (US)
Assigned to The Procter & Gamble Company, Cincinnati, OH (US)
Filed by The Procter & Gamble Company, Cincinnati, OH (US)
Filed on Sep. 30, 2020, as Appl. No. 17/37,766.
Claims priority of provisional application 62/994,893, filed on Mar. 26, 2020.
Claims priority of provisional application 62/985,451, filed on Mar. 5, 2020.
Claims priority of provisional application 62/972,111, filed on Feb. 10, 2020.
Claims priority of provisional application 62/972,109, filed on Feb. 10, 2020.
Claims priority of provisional application 62/943,940, filed on Dec. 5, 2019.
Claims priority of provisional application 62/907,733, filed on Sep. 30, 2019.
Claims priority of provisional application 62/907,736, filed on Sep. 30, 2019.
Claims priority of provisional application 62/907,735, filed on Sep. 30, 2019.
Prior Publication US 2021/0093525 A1, Apr. 1, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 8/27 (2006.01); A61K 8/9789 (2017.01); A61K 8/20 (2006.01); A61Q 11/00 (2006.01); A61K 8/21 (2006.01); A61K 8/362 (2006.01); A61K 8/365 (2006.01); A61K 8/44 (2006.01); A61K 8/73 (2006.01); A61K 8/81 (2006.01); A61K 8/97 (2017.01); A61K 8/24 (2006.01); A61K 8/35 (2006.01)
CPC A61K 8/27 (2013.01) [A61K 8/20 (2013.01); A61K 8/21 (2013.01); A61K 8/24 (2013.01); A61K 8/35 (2013.01); A61K 8/362 (2013.01); A61K 8/365 (2013.01); A61K 8/44 (2013.01); A61K 8/731 (2013.01); A61K 8/8147 (2013.01); A61K 8/97 (2013.01); A61K 8/9789 (2017.08); A61Q 11/00 (2013.01); A61K 2800/28 (2013.01); A61K 2800/30 (2013.01); A61K 2800/48 (2013.01); A61K 2800/74 (2013.01); A61K 2800/92 (2013.01)] 34 Claims
 
1. An oral care composition comprising:
(a) hops extract comprising hops beta acid and hops oils, wherein the hops extract comprises from greater than 0% to less than 2.5%, by weight of the hops extract, of the hops oils, wherein the oral care composition comprises from about 0.01% to about 10%, by weight of the composition, of the hops beta acid, and wherein the hops beta acid comprises only non-hydrogenated hops beta acids; and
(b) from about 0.01% to about 10%, by weight of the composition, of fluoride, wherein the fluoride is selected from the group consisting of sodium fluoride, sodium monofluorophosphate, amine fluoride, indium fluoride, and combinations thereof, wherein the composition is free of stannous fluoride,
wherein the oral care composition has a pH of greater than 7.